Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects
Clinical trial NCT04640012 · COMPLETED
Trial details
- NCT number
- NCT04640012
- Sponsor
- Guangzhou JOYO Pharma Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2021-03-19
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.